Evidence map›Paper›PMID 32575361›Full record

ArticleMetabolites2020

Tumor Tissue-Specific Biomarkers of Colorectal Cancer by Anatomic Location and Stage.

Yuping Cai, Nicholas J W Rattray, Qian Zhang, Varvara Mironova, Alvaro Santos-Neto, Engjel Muca, Ana K Rosen Vollmar, Kuo-Shun Hsu, Zahra Rattray, Justin R Cross and 4 more

Open access · goldAbstract read
In one paragraph

Article in Metabolites, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 1 pooled it
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 1 synthesis or guideline pooled it, 32 citations in OpenAlex.

  1. Colorectal neoplasia-specific amino acid profiles and their diagnostic potential: a systematic review.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2026
    Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Insight into Nephrotoxicity and Processing Mechanism ofDrug design, development and therapy · 2023
    Article
  10. Article
  11. Article
  12. Mass spectrometry imaging of L-[ring-Cancer & metabolism · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 4 institutions in 3 countries.

Yuping CaiDepartment of Environmental Health Sciences, Yale School of Public Health, Yale University, New Haven, CT 06520, USA.
Nicholas J W RattrayDepartment of Environmental Health Sciences, Yale School of Public Health, Yale University, New Haven, CT 06520, USA.ORCID 0000-0002-3528-6905
Qian ZhangDepartment of Environmental Health Sciences, Yale School of Public Health, Yale University, New Haven, CT 06520, USA.
Varvara MironovaDepartment of Environmental Health Sciences, Yale School of Public Health, Yale University, New Haven, CT 06520, USA.
Alvaro Santos-NetoDepartment of Environmental Health Sciences, Yale School of Public Health, Yale University, New Haven, CT 06520, USA.ORCID 0000-0003-1719-8458
Engjel MucaDepartment of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
Ana K Rosen VollmarDepartment of Environmental Health Sciences, Yale School of Public Health, Yale University, New Haven, CT 06520, USA.ORCID 0000-0002-8009-0258
Kuo-Shun HsuDepartment of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.ORCID 0000-0003-4826-506X
Zahra RattrayStrathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow G4 0RE, UK.
Justin R CrossCancer Biology and Genetics Program, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA.
Yawei ZhangDepartment of Environmental Health Sciences, Yale School of Public Health, Yale University, New Haven, CT 06520, USA.
Philip B PatyDepartment of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
Sajid A KhanDepartment of Surgery, Division of Surgical Oncology, Yale University School of Medicine, New Haven, CT 06520, USA.
Caroline H JohnsonDepartment of Environmental Health Sciences, Yale School of Public Health, Yale University, New Haven, CT 06520, USA.ORCID 0000-0002-5298-1299
Yale University · USMemorial Sloan Kettering Cancer Center · USUniversity of Strathclyde · GBUniversidade de São Paulo · BR

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Hongbiao Carl Lekaye · 1985 to 2026
$347.4M
Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
Understanding sex differences in colon cancer metabolismR21CA223686 · NCI · YALE UNIVERSITY · PI JOHNSON, CAROLINE HELEN, KHAN, SAJID A · 2018 to 2019
$394k
China Scholarship Council 201808230083Fundação de Amparo à Pesquisa do Estado de São Paulo 2018/01448-9NCATS NIH HHS UL1 TR001863NCI NIH HHS P30 CA008748NCI NIH HHS R21 CA223686NIH HHS NIH 1R21CA223686-01
6 · The paper itself

Abstract

The progress in the discovery and validation of metabolite biomarkers for the detection of colorectal cancer (CRC) has been hampered by the lack of reproducibility between study cohorts. The majority of discovery-phase biomarker studies have used patient blood samples to identify disease-related metabolites, but this pre-validation phase is confounded by non-specific disease influences on the metabolome. We therefore propose that metabolite biomarker discovery would have greater success and higher reproducibility for CRC if the discovery phase was conducted in tumor tissues, to find metabolites that have higher specificity to the metabolic consequences of the disease, that are then validated in blood samples. This would thereby eliminate any non-tumor and/or body response effects to the disease. In this study, we performed comprehensive untargeted metabolomics analyses on normal (adjacent) colon and tumor tissues from CRC patients, revealing tumor tissue-specific biomarkers (

Indexed as

colorectal cancer (CRC)metabolite biomarkersmetabolomics

Identifiers

PMID32575361
PMCPMC7345993
OpenAlexW3036836410

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.